[{"id":"066ab336-a212-45de-9f07-3f558dc780e8","acronym":"","url":"https://clinicaltrials.gov/study/NCT02746081","created_at":"2021-01-18T13:27:15.549Z","updated_at":"2025-02-25T17:08:45.816Z","phase":"Phase 1","brief_title":"Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors","source_id_and_acronym":"NCT02746081","lead_sponsor":"Bayer","biomarkers":" IDH1","pipe":" | ","alterations":" IDH1 mutation • IDH1 R132","tags":["IDH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH1 mutation • IDH1 R132"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BAY1436032"],"overall_status":"Completed","enrollment":" Enrollment 81","initiation":"Initiation: 05/26/2016","start_date":" 05/26/2016","primary_txt":" Primary completion: 11/08/2018","primary_completion_date":" 11/08/2018","study_txt":" Completion: 12/03/2024","study_completion_date":" 12/03/2024","last_update_posted":"2024-12-18"},{"id":"0b87e0db-cc5b-467d-a835-37405ce289f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT03127735","created_at":"2021-01-18T15:24:28.605Z","updated_at":"2025-02-25T17:09:42.244Z","phase":"Phase 2","brief_title":"BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)","source_id_and_acronym":"NCT03127735","lead_sponsor":"Bayer","biomarkers":" IDH1","pipe":" | ","alterations":" IDH1 mutation","tags":["IDH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH1 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BAY1436032"],"overall_status":"Completed","enrollment":" Enrollment 27","initiation":"Initiation: 06/14/2017","start_date":" 06/14/2017","primary_txt":" Primary completion: 12/06/2018","primary_completion_date":" 12/06/2018","study_txt":" Completion: 03/15/2019","study_completion_date":" 03/15/2019","last_update_posted":"2019-05-14"}]